Spectral Medical Inc T.EDT

Paradigm prognostications

[mercedesman]

Wondering if we'll see an update soon?

Where they reverse course on their original valuation of $ 4,  back to $ 2.10 (a mere 5 bagger) ?

You know, to  better reflect things like:

PMX

• Break Through Device Designation

• ramp of Tigris enrollment spring/summer 2022

• "greatly exceeding expecations" continues on pace

Dialco

• Selection of most (all?) partners on useability Trial

• Hiring of a big name in Sam Amory

• ARC deal

• "when, not if" on DIMI Trial

[Gorf79]

Analyst coverage here has been dismal, even laughable at best. I couldn't care less whether Paradigm forgot they were covering Spectral. It was never serious coverage anyhow. It's a 100% end game/buyout play MM, which makes the analyst coverage exactly what it is and has always been... Useless! If you are by like me, you consider the share price irrelevant. It's all about the many

[mercedesman]

I agree But it would be nice if the SP reflected more than 1/50th of the true underlying value of the assets. And if the Analyst target price reflected more than 1/10th of the true underlying value of the assets. Especially if they are not quite done with raising money, giving away value to "others", and taking sweeteners for themselves, every time that they do. With any luck they

[Gorf79]

There was some discussion in the past here about a Baxter takeout figure already being pre negotiated. It is certainly trading like that is the case...Zero linkage between SP and Asset Value. If that is the case who in management gives a sh$t about the day to day share price. It is likely so...

[JohnnyCashMoney]

155,000 at 2.78..... still quite a bargain